Literature DB >> 23959166

A bioengineered heterotypic stroma-cancer microenvironment model to study pancreatic ductal adenocarcinoma.

Cole R Drifka1, Kevin W Eliceiri, Sharon M Weber, W John Kao.   

Abstract

Interactions between neoplastic epithelial cells and components of a reactive stroma in pancreatic ductal adenocarcinoma (PDAC) are of key significance behind the disease's dismal prognosis. Despite extensive published research in the importance of stroma-cancer interactions in other cancers and experimental evidence supporting the importance of the microenvironment in PDAC progression, a reproducible three-dimensional (3D) in vitro model for exploring stroma-cancer interplay and evaluating therapeutics in a physiologically relevant context has been lacking. We introduce a humanized microfluidic model of the PDAC microenvironment incorporating multicellularity, extracellular matrix (ECM) components, and a spatially defined 3D microarchitecture. Pancreatic stellate cells (PSCs) isolated from clinically-evaluated human tissue specimens were co-cultured with pancreatic ductal adenocarcinoma cells as an accessible 3D construct that maintained important tissue features and disease behavior. Multiphoton excitation (MPE) and Second Harmonic Generation (SHG) imaging techniques were utilized to image the intrinsic signal of stromal collagen in human pancreatic tissues and live cell-collagen interactions within the optically-accessible microfluidic tissue model. We further evaluated the dose-response of the model with the anticancer agent paclitaxel. This bioengineered model of the PDAC stroma-cancer microenvironment provides a complementary platform to elucidate the complex stroma-cancer interrelationship and to evaluate the efficacy of potential therapeutics in a humanized system that closely recapitulates key PDAC microenvironment characteristics.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23959166      PMCID: PMC3834588          DOI: 10.1039/c3lc50487e

Source DB:  PubMed          Journal:  Lab Chip        ISSN: 1473-0189            Impact factor:   6.799


  82 in total

1.  Microfluidic patterning of cells in extracellular matrix biopolymers: effects of channel size, cell type, and matrix composition on pattern integrity.

Authors:  Wei Tan; Tejal A Desai
Journal:  Tissue Eng       Date:  2003-04

2.  Type I collagen promotes the malignant phenotype of pancreatic ductal adenocarcinoma.

Authors:  Thomas Armstrong; Graham Packham; Lindsay B Murphy; Adrian C Bateman; John A Conti; David R Fine; Colin D Johnson; R Christopher Benyon; John P Iredale
Journal:  Clin Cancer Res       Date:  2004-11-01       Impact factor: 12.531

Review 3.  The pancreatic stellate cell: a star on the rise in pancreatic diseases.

Authors:  M Bishr Omary; Aurelia Lugea; Anson W Lowe; Stephen J Pandol
Journal:  J Clin Invest       Date:  2007-01       Impact factor: 14.808

4.  Two-photon laser scanning fluorescence microscopy.

Authors:  W Denk; J H Strickler; W W Webb
Journal:  Science       Date:  1990-04-06       Impact factor: 47.728

Review 5.  Patient-derived tumour xenografts as models for oncology drug development.

Authors:  John J Tentler; Aik Choon Tan; Colin D Weekes; Antonio Jimeno; Stephen Leong; Todd M Pitts; John J Arcaroli; Wells A Messersmith; S Gail Eckhardt
Journal:  Nat Rev Clin Oncol       Date:  2012-04-17       Impact factor: 66.675

6.  Engineering fibrotic tissue in pancreatic cancer: a novel three-dimensional model to investigate nanoparticle delivery.

Authors:  Hitomi Hosoya; Koji Kadowaki; Michiya Matsusaki; Horacio Cabral; Hiroshi Nishihara; Hideaki Ijichi; Kazuhiko Koike; Kazunori Kataoka; Kohei Miyazono; Mitsuru Akashi; Mitsunobu R Kano
Journal:  Biochem Biophys Res Commun       Date:  2012-01-30       Impact factor: 3.575

7.  Pancreatic stellate cells: partners in crime with pancreatic cancer cells.

Authors:  Alain Vonlaufen; Swapna Joshi; Changfa Qu; Phoebe A Phillips; Zhihong Xu; Nicole R Parker; Cheryl S Toi; Romano C Pirola; Jeremy S Wilson; David Goldstein; Minoti V Apte
Journal:  Cancer Res       Date:  2008-04-01       Impact factor: 12.701

8.  Sonic hedgehog promotes desmoplasia in pancreatic cancer.

Authors:  Jennifer M Bailey; Benjamin J Swanson; Tomofumi Hamada; John P Eggers; Pankaj K Singh; Thomas Caffery; Michel M Ouellette; Michael A Hollingsworth
Journal:  Clin Cancer Res       Date:  2008-10-01       Impact factor: 12.531

9.  Alterations of the extracellular matrix in ovarian cancer studied by Second Harmonic Generation imaging microscopy.

Authors:  Oleg Nadiarnykh; Ronald B LaComb; Molly A Brewer; Paul J Campagnola
Journal:  BMC Cancer       Date:  2010-03-11       Impact factor: 4.430

10.  Quantitative analysis of collagen and collagen subtypes I, III, and V in human pancreatic cancer, tumor-associated chronic pancreatitis, and alcoholic chronic pancreatitis.

Authors:  T Imamura; H Iguchi; T Manabe; G Ohshio; T Yoshimura; Z H Wang; H Suwa; S Ishigami; M Imamura
Journal:  Pancreas       Date:  1995-11       Impact factor: 3.327

View more
  19 in total

Review 1.  Integrated micro/nanoengineered functional biomaterials for cell mechanics and mechanobiology: a materials perspective.

Authors:  Yue Shao; Jianping Fu
Journal:  Adv Mater       Date:  2013-12-12       Impact factor: 30.849

2.  Methods for Quantifying Fibrillar Collagen Alignment.

Authors:  Yuming Liu; Adib Keikhosravi; Guneet S Mehta; Cole R Drifka; Kevin W Eliceiri
Journal:  Methods Mol Biol       Date:  2017

3.  Comparison of Picrosirius Red Staining With Second Harmonic Generation Imaging for the Quantification of Clinically Relevant Collagen Fiber Features in Histopathology Samples.

Authors:  Cole R Drifka; Agnes G Loeffler; Kara Mathewson; Guneet Mehta; Adib Keikhosravi; Yuming Liu; Stephanie Lemancik; William A Ricke; Sharon M Weber; W John Kao; Kevin W Eliceiri
Journal:  J Histochem Cytochem       Date:  2016-07-22       Impact factor: 2.479

4.  Periductal stromal collagen topology of pancreatic ductal adenocarcinoma differs from that of normal and chronic pancreatitis.

Authors:  Cole R Drifka; Jo Tod; Agnes G Loeffler; Yuming Liu; Gareth J Thomas; Kevin W Eliceiri; W John Kao
Journal:  Mod Pathol       Date:  2015-09-04       Impact factor: 7.842

Review 5.  Microfluidic models for adoptive cell-mediated cancer immunotherapies.

Authors:  Giulia Adriani; Andrea Pavesi; Anthony T Tan; Antonio Bertoletti; Jean Paul Thiery; Roger D Kamm
Journal:  Drug Discov Today       Date:  2016-05-13       Impact factor: 7.851

6.  Automated quantification of aligned collagen for human breast carcinoma prognosis.

Authors:  Jeremy S Bredfeldt; Yuming Liu; Matthew W Conklin; Patricia J Keely; Thomas R Mackie; Kevin W Eliceiri
Journal:  J Pathol Inform       Date:  2014-08-28

7.  Characterization of fibrillar collagens and extracellular matrix of glandular benign prostatic hyperplasia nodules.

Authors:  Tyler M Bauman; Tristan M Nicholson; Lisa L Abler; Kevin W Eliceiri; Wei Huang; Chad M Vezina; William A Ricke
Journal:  PLoS One       Date:  2014-10-02       Impact factor: 3.240

8.  Microfluidic co-culture of pancreatic tumor spheroids with stellate cells as a novel 3D model for investigation of stroma-mediated cell motility and drug resistance.

Authors:  Ji-Hyun Lee; Seul-Ki Kim; Iftikhar Ali Khawar; Su-Yeong Jeong; Seok Chung; Hyo-Jeong Kuh
Journal:  J Exp Clin Cancer Res       Date:  2018-01-12

9.  A novel microfluidic 3D platform for culturing pancreatic ductal adenocarcinoma cells: comparison with in vitro cultures and in vivo xenografts.

Authors:  Meike Beer; Nirmala Kuppalu; Matteo Stefanini; Holger Becker; Ingo Schulz; Sagar Manoli; Julia Schuette; Christian Schmees; Armando Casazza; Martin Stelzle; Annarosa Arcangeli
Journal:  Sci Rep       Date:  2017-04-25       Impact factor: 4.379

10.  Highly aligned stromal collagen is a negative prognostic factor following pancreatic ductal adenocarcinoma resection.

Authors:  Cole R Drifka; Agnes G Loeffler; Kara Mathewson; Adib Keikhosravi; Jens C Eickhoff; Yuming Liu; Sharon M Weber; W John Kao; Kevin W Eliceiri
Journal:  Oncotarget       Date:  2016-11-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.